P

P




Paraneoplastic Syndromes









































































Paraneoplastic Disorder Clinical Features Associated Neoplasms in Companion Animals
Malignancy-associated hypercalcemia Dehydration, depression, muscular weakness, anorexia, polyuria and polydipsia, vomiting, arrhythmias Lymphoma (thymic, multicentric, extranodal leukemia), carcinomas (nasal, pulmonary, mammary, squamous cell, thyroid, apocrine gland of anal sac, gastric, pancreatic, testicular, parathyroid gland), thymomas, multiple myeloma, epidermoid carcinoma of the lung
Extrapancreatic hypoglycemia Weakness, seizures Hepatocellular carcinoma, hepatoma, hemangiosarcoma, leiomyosarcoma, splenic hemangiosarcoma, salivary gland adenocarcinoma, metastatic oral melanoma, mammary carcinoma, pulmonary carcinoma, plasma cell tumor, lymphocytic leukemia, renal carcinoma
Hyperhistaminemia, mast cell degranulation Gastrointestinal ulceration with melena and hematemesis, urticaria, erythema, pruritus, poor wound healing, anaphylactoid reaction, hypotension/arrhythmias, altered coagulation Mast cell tumor
Cancer anorexia/cachexia syndrome Weight loss >5%-10% body weight, anorexia >2-3 days’ duration, early satiety Any tumors
Syndrome of inappropriate antidiuretic hormone secretion Hyponatremia, polyuria and polydipsia, edema Pulmonary carcinoma (dog)
Fever Persistent pyrexia >39.7°C (103°F) without infection Lymphoproliferative and myeloproliferative neoplasms; mast cell, hepatic, and brain tumors
Polycythemia Exercise intolerance, seizures, red mucous membranes, packed cell volume >60 Renal tumors, lymphoma, polycythemia vera, hepatic tumors
Hypertrophic osteopathy Painful, hard, swollen distal limbs, reluctance to walk Primary lung tumors, rhabdomyosarcoma (bladder), esophageal sarcomas, pulmonary metastasis, carcinoma, renal carcinomas, hepatic adenocarcinoma, renal papillary adenoma (cat), Sertoli cell tumor, transitional cell carcinoma of bladder, adrenocortical carcinoma
Dermatologic disorders Nodular dermatofibrosis, erythema, flushing, necrolytic migratory erythema Renal cystadenocarcinoma, mast cell tumor, pheochromocytoma, pancreatic adenocarcinoma
Renal disorders Amyloid deposition, glomerulonephritis, concentrating defects, proteinuria, nephrotic syndrome Many tumors, including lymphoma, plasma cell tumors, mast cell tumors
Central nervous system dysfunction Tissue hypoxia with or without thromboembolism, due to hyperviscosity syndrome (seizures, dementia) Lymphoma, plasma cell tumors
Peripheral nervous system disorders:    
Neuromuscular junction Myasthenia gravis (weakness with exercise that improves with rest) Thymoma, hepatocellular carcinoma, osteosarcoma, mammary adenocarcinoma, pheochromocytoma, pulmonary adenocarcinoma
Neuropathy Weakness, cranial nerve abnormalities Lymphoma, bronchogenic carcinoma, insulinoma, leiomyosarcoma, hemangiosarcoma, and undifferentiated sarcomas
Neuromyopathy Weakness, muscle pain, proprioception deficits Pulmonary carcinoma
Myopathy Myositis Thymoma

With permission from Bonagura J: Kirk’s current veterinary therapy XII: small animal practice, St Louis, 1995, Saunders, p 531.






Petechiae, Ecchymosis




From Ettinger S, Feldman E: Textbook of veterinary internal medicine, ed 5, St Louis, 2000, Saunders.








Pneumonia, Bacteria Isolated in Tracheal Aspirates from Dogs

























































































Bacteria Range Percentage (%)
Gram Negative
Escherichia coli 17–43
Klebsiella 3.9–23
Bordetella 3–23
Pseudomonas 4.9–33
Pasteurella 0–45
Enterobacter 0–5
Acinetobacter 0–7
Moraxella 2–26
Other gram-negative rods 4.4–12
Gram Positive
Staphylococcus 5.4–27
Streptococcus 13.8–47
Nonhemolytic 0–13
α-Hemolytic 3–30
β-Hemolytic 0–16
Corynebacterium 0–5
Mycoplasma 2.9–100
Anaerobes
Total 18.7
Bacteroides 23.7
Clostridium perfringens 5.3
Eubacterium 2.6
Fusobacterium 15.8
Peptostreptococcus 23.7
Prevotella 5.3
Porphyromonas 15.8
Propionibacterium 2.6

From pharyngeal isolates, Mycoplasma are isolated 85.7%-100% of the time, representing normal microflora; from transtracheal washings, 34%-69%; from bronchiolar washings, 7.1%-26.9% (Jameson et al., 1995; Randolph et al., 1993). A range is not listed for anaerobes because data are from one study of 203 dogs (Angus et al., 1997); Data taken from Creighton SR, Wilkins RJ: Bacteriologic and cytologic evaluation of animals with lower respiratory tract disease using transtracheal aspiration biopsy. J Am Anim Hosp Assoc 10:227–232, 1974 (30 dogs); Harpster NK: The effectiveness of the cephalosporins in the treatment of bacterial pneumonias in the dog. J Am Anim Hosp Assoc 17:766–772, 1981 (30 dogs); Thayer GW, Robinson SK: Bacterial bronchopneumonia in the dog: a review of 42 cases. J Am Anim Hosp Assoc 20:731–735, 1984 (42 dogs); Hirsh DC: Bacteriology of the lower respiratory tract. In Kirk RW (ed), Current veterinary therapy IX. Philadelphia, 1986, WB Saunders, pp 247–250 (105 dogs); Jameson PH, King LA, Lappin MR, et al: Comparison of clinical signs, diagnostic findings, organisms isolated, and clinical outcome in dogs with bacterial pneumonia: 93 cases (1986-1991). J Am Vet Med Assoc 206:206–209, 1995 (48 dogs); Angus JC, Jang SS, Hirsh DC: Microbiological study of trans-tracheal aspirates from dogs with suspected lower respiratory tract disease: 264 cases (1989-1995). J Am Vet Med Assoc 218:55–58, 1997 (203 dogs); With permission from Greene C: Infectious diseases of the dog and cat, ed 3, St Louis, 2006, Saunders, p 870.

< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 24, 2016 | Posted by in SMALL ANIMAL | Comments Off on P

Full access? Get Clinical Tree

Get Clinical Tree app for offline access